If the
INJUSDT
pair fails to reclaim $14.40, which marks the range high, I'm anticipating a pullback to the mid-range, approximately around $7.80.
A healthy correction might take it to the range quarter, which is around $4.50.
If things take a turn for the worse, yearly lows could come into play, but given INJ's strong performance in this bear market, this outcome appears unlikely.
Follow, like the idea and feel free to leave a comment.
Check out other ideas if you like this one.
INJUSDT
pair fails to reclaim $14.40, which marks the range high, I'm anticipating a pullback to the mid-range, approximately around $7.80. A healthy correction might take it to the range quarter, which is around $4.50.
If things take a turn for the worse, yearly lows could come into play, but given INJ's strong performance in this bear market, this outcome appears unlikely.
Follow, like the idea and feel free to leave a comment.
Check out other ideas if you like this one.
Order avbruten